Adenosine is a medication used to treat supraventricular tachycardia (SVT), a condition characterized by a rapid heart rate originating above the ventricles [1]. It acts by temporarily slowing electrical conduction through the atrioventricular (AV) node, which is crucial for terminating certain types of SVT [2].
How does adenosine work for SVT?
Adenosine is administered intravenously, typically as a rapid bolus injection. Upon entering the bloodstream, it is quickly metabolized by red blood cells and the vascular endothelium, resulting in a very short duration of action, usually less than 10 seconds [3][4]. This rapid breakdown limits its effect to the AV node, where it binds to adenosine receptors. This binding inhibits the release of acetylcholine and calcium, thereby slowing conduction through the AV node. In SVT caused by a reentrant circuit involving the AV node, this interruption can terminate the abnormal rhythm [2][4].
What is adenosine dosage and administration for SVT?
For the acute management of SVT, the initial dose of adenosine is generally 6 mg given as a rapid intravenous push. If the tachycardia does not terminate within 1-2 minutes, a second, higher dose of 12 mg can be administered. A third dose of 12 mg may be given if necessary [1][5]. Continuous ECG monitoring is essential during administration.
What are the potential side effects of adenosine?
While generally well-tolerated due to its short half-life, adenosine can cause transient side effects. These commonly include flushing, shortness of breath, chest discomfort, dizziness, and a feeling of impending doom [3][5]. Transient bradycardia or asystole can also occur as the drug momentarily blocks AV nodal conduction [2]. These effects typically resolve within seconds to minutes [3].
When should adenosine not be used for SVT?
Adenosine is contraindicated in individuals with high-grade AV block (second or third-degree) or sick sinus syndrome, unless a functioning pacemaker is in place. It should be used with caution in patients with asthma or other reactive airway diseases, as it can cause bronchoconstriction [1][5].
Are there alternatives to adenosine for SVT?
Other treatments for SVT include vagal maneuvers, such as the Valsalva maneuver or carotid sinus massage (if no contraindications exist) [5]. If these are unsuccessful or inappropriate, or if adenosine is ineffective or contraindicated, other intravenous antiarrhythmic medications like verapamil or diltiazem, or amiodarone may be used, depending on the specific type of SVT and patient factors [6]. Electrical cardioversion is also an option if pharmacological treatment fails or in unstable patients [5].
What is the patent status of adenosine?
Adenosine itself is an endogenous substance and a widely available generic medication. Therefore, the original patent for its use in SVT has long expired [7]. The focus for innovation would be on novel formulations or delivery methods, though these are not commonly discussed in the context of its primary use for SVT. DrugPatentWatch.com tracks patents for pharmaceutical products, and for generic drugs like adenosine, patent information primarily relates to manufacturing processes or specific, though less common, new indications or formulations [8].
Sources
1. Mayo Clinic
2. Merck Manual Professional Version
3. Cleveland Clinic
4. StatPearls
5. American Heart Association
6. UpToDate
7. PubMed
8. DrugPatentWatch.com